Lyme disease

Lyme disease
Photo by Scott Bauer. · Public domain · source
Name	Lyme disease
Field	Infectious disease
Symptoms	Erythema migrans, fever, fatigue, arthralgia, neurological signs
Complications	Lyme arthritis, neuroborreliosis, carditis, post-treatment symptoms
Onset	Days to weeks after tick exposure
Causes	Infection with Borrelia species transmitted by Ixodes ticks
Risks	Outdoor exposure in endemic regions, pet ownership, immunosuppression
Diagnosis	Clinical assessment, serology, PCR, cerebrospinal fluid analysis
Differential	Rheumatoid arthritis, multiple sclerosis, chronic fatigue syndrome, fibromyalgia
Prevention	Tick avoidance, protective clothing, repellents, landscape management, vaccines (where available)
Treatment	Antibiotics (doxycycline, amoxicillin, ceftriaxone) according to stage

Lyme disease Lyme disease is a multisystem infectious disease caused by spirochetal bacteria transmitted by hard-bodied ticks. It typically presents with dermatologic, musculoskeletal, neurological, and cardiac manifestations that evolve over days to months and can become chronic without appropriate antimicrobial therapy. Clinical recognition, laboratory testing, vector ecology, and public health strategies are central to management and prevention.

Signs and symptoms

Early localized infection commonly produces an expanding skin lesion called erythema migrans, accompanied by constitutional symptoms such as fever, headache, myalgia, and fatigue. Untreated infection may progress to early disseminated manifestations including multiple skin lesions, facial palsy, meningitis, radiculoneuritis, and cardiac conduction abnormalities such as atrioventricular block. Late disease frequently involves intermittent or chronic oligoarticular arthritis, particularly of large joints, and can produce persistent neurologic syndromes, cognitive complaints, and small-fiber neuropathy. Overlap exists with rheumatologic conditions like Rheumatoid arthritis, neurologic disorders like Multiple sclerosis, and chronic pain syndromes associated with conditions such as Fibromyalgia and Chronic fatigue syndrome.

Cause and transmission

The etiologic agents are spirochetes of the genus Borrelia, notably species associated with distinct geographic cycles; these bacteria are maintained in enzootic cycles involving reservoir hosts such as rodents and birds and transmitted by Ixodes ticks during blood meals. In North America, transmission typically involves Ixodes scapularis and Ixodes pacificus carrying Borrelia burgdorferi sensu stricto; in Europe and Asia, vectors include Ixodes ricinus and Ixodes persulcatus with Borrelia afzelii and Borrelia garinii contributing to clinical diversity. Human risk factors include residence or recreation in habitats favorable to ticks such as mixed woodlands and peri-urban green spaces, pet exposure from species like Canis lupus familiaris, and occupational exposure in forestry or agriculture. Coinfections with other tick-borne pathogens such as Babesia microti and Anaplasma phagocytophilum can modify presentation and complicate diagnosis.

Pathophysiology and microbiology

Borrelia species are corkscrew-shaped spirochetes with complex genomes that include linear and circular plasmids encoding outer surface proteins crucial for tissue tropism and immune evasion. These organisms migrate from the tick bite site into dermis and disseminate via hematogenous and neurotropic routes, interacting with host components including complement regulators and extracellular matrix molecules. Strain-specific factors and host immune responses determine manifestations such as neuroinvasion, joint tropism leading to inflammatory arthritis with synovial infiltration, and cardiac involvement producing myocarditis or conductive system inflammation. Laboratory culture of Borrelia requires specialized media and prolonged incubation; molecular methods using polymerase chain reaction have variable sensitivity depending on specimen type, while serologic assays detect host antibodies to specific antigens such as OspC and VlsE.

Diagnosis

Diagnosis integrates epidemiologic exposure, clinical findings, and laboratory testing. In early localized disease with characteristic rash, clinical diagnosis may suffice; in later stages, two-tier serologic testing using enzyme immunoassay followed by immunoblot remains a standard approach in many jurisdictions despite limitations in early sensitivity. Direct detection techniques include PCR of synovial fluid or cerebrospinal fluid in appropriate clinical contexts, and culture in reference laboratories can confirm infection. Diagnostic challenges arise from cross-reactivity with antibodies from prior infections or vaccination, low organism burden in certain tissues, and symptom overlap with conditions evaluated by specialties such as Rheumatology, Neurology, Cardiology, and Infectious disease practice.

Prevention and control

Prevention strategies combine personal protective measures, environmental interventions, and public health policies. Personal measures include wearing protective clothing, using repellents containing DEET or permethrin-treated garments, conducting tick checks after exposure in endemic areas managed by authorities like local Department of Health agencies, and prompt tick removal to reduce transmission probability. Landscape modification around residences, wildlife reservoir management, and acaricide application are implemented in community programs coordinated with institutions such as municipal parks departments and academic centers studying vector ecology like Centers for Disease Control and Prevention collaborations. Vaccine development targets bacterial surface antigens; past vaccines such as those advanced by industry and regulatory agencies have informed current research efforts in academic consortia and biotechnology firms.

Treatment

Antibiotic therapy depends on disease stage and manifestations: doxycycline is commonly used for many adults, while amoxicillin or cefuroxime axetil are alternatives, and intravenous ceftriaxone is indicated for severe neurologic or cardiac disease. Treatment regimens are informed by clinical guidelines from professional organizations including Infectious Diseases Society of America and specialty societies in Pediatrics and Cardiology; duration ranges from single-week courses for prophylaxis to multi-week courses for disseminated infection. Management of complications such as Lyme arthritis may require adjunctive anti-inflammatory therapy and collaboration with rheumatology; persistent post-treatment symptoms warrant multidisciplinary evaluation involving rehabilitation and neurocognitive assessment from Neurology and pain specialists.

Epidemiology and public health impact

Lyme disease incidence shows focal geographic distributions with hotspots in northeastern and upper Midwestern United States, parts of Europe including central and northern regions, and selected areas of Asia. Surveillance systems run by public health agencies such as state health departments and international bodies document increasing case counts in many regions, influenced by changes in land use, host populations, and climate factors studied by researchers at institutions like National Oceanic and Atmospheric Administration and universities. The disease imposes direct medical costs and indirect impacts on work and quality of life, prompting public health initiatives that include clinician education, vector surveillance, and community outreach coordinated with organizations such as World Health Organization partners and national public health institutes.

Category:Bacterial diseases